1. Home
  2. FRES vs MIRA Comparison

FRES vs MIRA Comparison

Compare FRES & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • MIRA
  • Stock Information
  • Founded
  • FRES 2010
  • MIRA 2020
  • Country
  • FRES United States
  • MIRA United States
  • Employees
  • FRES N/A
  • MIRA N/A
  • Industry
  • FRES Medical Specialities
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRES Health Care
  • MIRA Health Care
  • Exchange
  • FRES Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • FRES N/A
  • MIRA 17.1M
  • IPO Year
  • FRES 2020
  • MIRA 2023
  • Fundamental
  • Price
  • FRES $1.66
  • MIRA $1.05
  • Analyst Decision
  • FRES
  • MIRA Strong Buy
  • Analyst Count
  • FRES 0
  • MIRA 2
  • Target Price
  • FRES N/A
  • MIRA $14.00
  • AVG Volume (30 Days)
  • FRES 32.8K
  • MIRA 538.5K
  • Earning Date
  • FRES 10-29-2024
  • MIRA 11-11-2024
  • Dividend Yield
  • FRES N/A
  • MIRA N/A
  • EPS Growth
  • FRES N/A
  • MIRA N/A
  • EPS
  • FRES N/A
  • MIRA N/A
  • Revenue
  • FRES $2,341,326.00
  • MIRA N/A
  • Revenue This Year
  • FRES N/A
  • MIRA N/A
  • Revenue Next Year
  • FRES N/A
  • MIRA N/A
  • P/E Ratio
  • FRES N/A
  • MIRA N/A
  • Revenue Growth
  • FRES 94.50
  • MIRA N/A
  • 52 Week Low
  • FRES $1.11
  • MIRA $0.51
  • 52 Week High
  • FRES $18.00
  • MIRA $6.40
  • Technical
  • Relative Strength Index (RSI)
  • FRES 51.75
  • MIRA 38.49
  • Support Level
  • FRES $1.51
  • MIRA $1.05
  • Resistance Level
  • FRES $2.36
  • MIRA $1.12
  • Average True Range (ATR)
  • FRES 0.19
  • MIRA 0.07
  • MACD
  • FRES 0.06
  • MIRA 0.02
  • Stochastic Oscillator
  • FRES 38.60
  • MIRA 12.00

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: